Home
News
Create
Screeners
Insights
Titan Biotech
397.
90
+0.85
(+0.21%)
Market Cap
₹1,644.11 Cr
PE Ratio
54.92
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+0.21%
1M
-15.80%
6M
+80.61%
1Y
+393.18%
5Y
+436.40%
View Company Insights
Latest news about Titan Biotech
Titan Biotech closes trading window from July 1 for Q1FY26 results
6 days ago
Titan Biotech Ltd closed its trading window on July 1, 2026, for insiders until 48 hours post Q1FY26 results announcement, adhering to SEBI regulations. The board meeting date for the June 2026 quarter results is pending.
Titan Biotech FY26 net profit rises 50% to ₹2,744.72 lakh
Jun 01, 2026
Titan Biotech board to consider FY26 results on May 30
May 20, 2026
Titan Biotech Launches Second 'Saksham Niveshak' Campaign to Address Unclaimed Dividends
May 06, 2026
Titan Biotech Limited Opens Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares
May 06, 2026
More news about Titan Biotech
04
May 26
Titan Biotech Limited Submits Annual Secretarial Compliance Report for Financial Year Ended March 31, 2026
Titan Biotech Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, with BSE Limited on May 4, 2026, pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015. The report, issued by Practicing Company Secretary Mr. Amit Anand (M No: ACS-13409, CP No: 17101) on April 24, 2026, confirmed full compliance across all applicable SEBI regulations with no deviations, violations, or regulatory actions recorded. Key compliance areas including secretarial standards, insider trading norms, related party transactions, and website disclosures were all found to be in order. No material subsidiary was identified during the review period, and no observations from previous reports remained unaddressed.
06
Apr 26
Titan Biotech Limited Files Regulatory Notice for Lost Share Certificates with BSE
Titan Biotech Limited filed a regulatory notice with BSE Limited on 06/04/2026 regarding newspaper advertisements for lost share certificates. The filing, submitted by Compliance Officer Charanjit Singh, includes publications in English and Hindi newspapers and will be hosted on the company's website, demonstrating standard corporate governance compliance for the ISO 9001:2015 certified company.
04
Apr 26
Titan Biotech Limited Submits SEBI Compliance Certificate for Q4 FY26
Titan Biotech Limited filed its Q4 FY26 compliance certificate under SEBI Regulation 74(5) on April 4, 2026, covering the quarter ended March 31, 2026. The certificate, prepared based on confirmation from registrar Beetal Financial & Computer Services (P) Ltd, confirms proper handling of dematerialization processes including timely processing of securities, mutilation of certificates, and substitution of depositories as registered owners within mandated timeframes.
Titan Biotech
397.
90
+
0.
85
(+
0.
21
%)
1 Year Returns:
+393.18%
Industry Peers
Pidilite Industries
1,599.60
(+
0.
16
%)
SRF
2,664.70
(-
2.
50
%)
Gujarat Fluorochemicals
3,872.30
(-
0.
94
%)
Navin Fluorine International
7,486.50
(-
1.
61
%)
Himadri Speciality Chemical
675.50
(-
0.
38
%)
Deepak Nitrite
1,563.70
(-
3.
62
%)
Atul
6,608.50
(-
0.
93
%)
Aether Industries
1,342.20
(+
1.
29
%)
Aarti Industries
457.20
(-
1.
90
%)
Fine Organic Industries
5,334.10
(+
1.
87
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar